University Medical Center Groningen
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1614-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.umcg.nl
Safety and Efficacy Study of Add On Aliskiren in Patients With Heart Failure and Renal Impairment
- First Posted Date
- 2009-04-15
- Last Posted Date
- 2013-05-17
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 41
- Registration Number
- NCT00881439
- Locations
- 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
Study to Assess the Effects of High Protein Diet in Obesity, the LOWER Study
Not Applicable
Completed
- Conditions
- Obesity
- Interventions
- Dietary Supplement: High protein energy-restrictedDietary Supplement: Normal protein energy-restricted
- First Posted Date
- 2009-03-17
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 317
- Registration Number
- NCT00862953
- Locations
- 🇳🇱
Hospital Hengelo, Hengelo, Netherlands
Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors
Phase 2
Terminated
- Conditions
- High-Risk Breast Cancer
- First Posted Date
- 2009-02-25
- Last Posted Date
- 2009-02-25
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 50
- Registration Number
- NCT00851110
- Locations
- 🇳🇱
Free University Hospital, Amsterdam, Netherlands
🇳🇱The Netherlands Cancer Institute, Amsterdam, Netherlands
🇳🇱Academic Medical Center, Amsterdam, Netherlands
Effects of Smoking on Bronchial Epithelium
Completed
- Conditions
- AsthmaCopd
- First Posted Date
- 2009-02-23
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 60
- Registration Number
- NCT00849433
- Locations
- 🇳🇱
University Medical Centre Groningen, Groningen, Netherlands
A Study to Obtain Normal Values of Inflammatory Variables From Healthy Subjects
Completed
- Conditions
- AsthmaCopd
- First Posted Date
- 2009-02-20
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 120
- Registration Number
- NCT00848406
- Locations
- 🇳🇱
University Medical Centre Groningen, Groningen, Netherlands
Withdrawal Versus Continuation of Amiodarone in Successfully Treated Patients With Persistent Atrial Fibrillation
Phase 4
Completed
- Conditions
- Persistent Atrial Fibrillation
- Interventions
- Drug: withdrawal or continuation of amiodarone therapy
- First Posted Date
- 2009-02-18
- Last Posted Date
- 2009-06-24
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 37
- Registration Number
- NCT00845780
- Locations
- 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer
Phase 2
Completed
- Conditions
- Ovarian Cancer
- First Posted Date
- 2009-02-16
- Last Posted Date
- 2011-02-25
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 19
- Registration Number
- NCT00844506
- Locations
- 🇳🇱
University Medical Centre Groningen, Groningen, Netherlands
VEGF Imaging in Renal Cell Carcinoma
Completed
- Conditions
- Renal Cell Carcinoma
- Interventions
- Other: 89Zr-Bevacizumab PET-scan
- First Posted Date
- 2009-01-29
- Last Posted Date
- 2024-05-06
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 26
- Registration Number
- NCT00831857
- Locations
- 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model
Not Applicable
- Conditions
- Ischemia-Reperfusion InjuryMyocardial Infarction
- Interventions
- Drug: NaClDrug: Epoetin alpha
- First Posted Date
- 2008-06-05
- Last Posted Date
- 2010-03-12
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 12
- Registration Number
- NCT00691613
- Locations
- 🇳🇱
Clinical Research Centre Nijmegen, Nijmegen, Gelderland, Netherlands
Side Effects of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) Directed Therapy
Terminated
- Conditions
- Metastatic Malignancies
- First Posted Date
- 2008-04-14
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 73
- Registration Number
- NCT00657098
- Locations
- 🇳🇱
University Medical Center Groningen, Groningen, Netherlands